Passive smoking exposure is known to cause adverse health outcomes, but what is the association between passive smoking exposure and the risk of hypertension? In this Q&A, Onoja Apka, PhD, answered...
In this Q and A, Chief Investigator of the EMPA-KIDNEY trial, William Herrington, MA, MBBS, MD, answers questions about the results of the trial, including the effects of the SGLT2 inhibitor, empagliflozin,...
Ikuo Hirano, MD, the Chair of the Writing Committee, answers questions about the ACG/JTF guidelines on the management of patients with eosinophilic esophagitis.
In this Q&A, Manuel Castillo-Angeles, MD, MPH, postdoctoral research fellow at the Center for Surgery and Public Health, Brigham and Women’s Hospital discusses the results of a recent study on the effects...
